August 21, 2020
AmerisourceBergen Corp.'s board of directors is asking a Delaware federal court to throw out claims by shareholders that it ignored "red flags" that opioids the company produced were being diverted, saying in a brief unsealed Friday that it actively sought to curtail misuse of the opioids.